Nancy Dreyer, PhD, MPH, FISPe, discusses the importance of DIA to the industry.
Stewart Geary, MD, discusses how global drug development benefits from DIA.
Michael R. Hamrell, PhD, discusses the impact of DIA on professional development.
Moe Alsumidae discusses how DIA's neutral platform grows industry collaboration and communication.
Tim Callahan, PhD, discusses the scientific benefit of DIA
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.